The London Company released its third-quarter 2025 investor letter, reporting a 6.3% return. The portfolio outperformed the Russell 1000 Index, driven by US equity rally and strong corporate earnings. Check out the top 5 holdings for 2025 picks. Bruker Corporation (BRKR) was highlighted as a stock with a one-month return of 6.17%.

The London Company decided to exit its position in Bruker Corporation (BRKR) due to underperformance since 2024. Weak pharma spending, funding cuts, and tariff concerns contributed to the decision. The stock hit a soft stop loss, prompting the move to fund a higher-conviction idea.

Bruker Corporation (BRKR) is not among the 30 most popular stocks among hedge funds. While its potential as an investment is acknowledged, certain AI stocks are seen to offer greater upside potential with less downside risk. For those seeking an undervalued AI stock benefiting from tariffs and onshoring, check out the free report on the best short-term AI stock.

In another article, Bruker Corporation (BRKR) was mentioned in a list of best medical device stocks to invest in. For more investor letters from hedge funds and leading investors, visit the hedge fund investor letters Q3 2025 page.

Read more at Yahoo Finance: London Company Large Cap Sold Its Holdings in Bruker Corporation (BRKR) in Q3